Detalhe da pesquisa
1.
Clinical features and prognostic factors of Magnusiomyces (Saprochaete) infections in haematology. A multicentre study of SEIFEM/Fungiscope.
Mycoses
; 66(1): 35-46, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36064299
2.
In vitro effect of eltrombopag alone and in combination with azacitidine on megakaryopoiesis in patients with myelodysplastic syndrome.
Platelets
; 32(3): 378-382, 2021 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32268817
3.
Systemic mastocytosis revisited with an emphasis on skeletal manifestations.
Radiol Med
; 126(4): 585-598, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33242205
4.
Pulmonary infections in patients with myelodysplastic syndromes receiving frontline azacytidine treatment.
Hematol Oncol
; 38(2): 189-196, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31891213
5.
Candidaemia in haematological malignancy patients from a SEIFEM study: Epidemiological patterns according to antifungal prophylaxis.
Mycoses
; 63(9): 900-910, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32531854
6.
Impact of invasive aspergillosis occurring during first induction therapy on outcome of acute myeloid leukaemia (SEIFEM-12B study).
Mycoses
; 63(10): 1094-1100, 2020 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-32697010
7.
Fungaemia in haematological malignancies: SEIFEM-2015 survey.
Eur J Clin Invest
; 49(5): e13083, 2019 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-30735240
8.
A bronchoalveolar lavage-driven antimicrobial treatment improves survival in hematologic malignancy patients with detected lung infiltrates: A prospective multicenter study of the SEIFEM group.
Am J Hematol
; 94(10): 1104-1112, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31321791
9.
Invasive aspergillosis in acute myeloid leukemia: Are we making progress in reducing mortality?
Med Mycol
; 55(1): 82-86, 2017 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27915304
10.
Familial occurrence of systemic and cutaneous mastocytosis in an adult multicentre series.
Br J Haematol
; 193(4): 845-848, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33754335
11.
Real-life use of erythropoiesis-stimulating agents in myelodysplastic syndromes: a "Gruppo Romano Mielodisplasie (GROM)" multicenter study.
Ann Hematol
; 95(7): 1059-65, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27091349
12.
Standard dose and prolonged administration of azacitidine are associated with improved efficacy in a real-world group of patients with myelodysplastic syndrome or low blast count acute myeloid leukemia.
Eur J Haematol
; 96(4): 344-51, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26018238
13.
Prevalence, severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes.
Br J Haematol
; 168(3): 361-70, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25272332
14.
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT.
Ann Hematol
; 99(1): 207-209, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31832752
15.
Deferasirox chelation therapy in patients with transfusion-dependent MDS: a 'real-world' report from two regional Italian registries: Gruppo Romano Mielodisplasie and Registro Basilicata.
Eur J Haematol
; 95(1): 52-6, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25764148
16.
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias.
Am J Hematol
; 90(5): E80-5, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25653205
17.
Aggressive Light Chain Myeloma Originating a Double Peak on Serum Electrophoresis: What's Underneath?
Acta Haematol
; 143(1): 91-92, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31269483
18.
Mutational profile and haematological response to iron chelation in myelodysplastic syndromes (MDS).
Br J Haematol
; 185(5): 954-957, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30407614
19.
Why methylation is not a marker predictive of response to hypomethylating agents.
Haematologica
; 99(4): 613-9, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24688109
20.
Risk of infectious complications in patients with chronic lymphocytic leukemia in the era of BCR inhibitors: a retrospective single institution experience.
Hematol Oncol
; 37(4): 496-497, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31017684